AEM vs EQX

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Equinox Gold presents a stark contrast between valuation and fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is attractively valued with a Forward P/E of 7.91 and a strong analyst target of $23.00, the deterministic health metrics indicate significant operational instability. Recent price performance has been exceptional over the last year, but a 0/100 technical trend and a massive -83.33% Q/Q revenue decline suggest a looming correction or operational pivot. The investment profile is currently speculative, relying on gold price tailwinds rather than internal financial strength.